-
EP3740497
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3740497
| EP3740497 - ENHANCED IMMUNOGENICITY FOR GPI-ANCHORED ANTIGENS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.10.2020 Database last updated on 03.09.2024 | |
| Former | The international publication has been made Status updated on 27.07.2019 | Most recent event Tooltip | 26.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states NantBio, Inc. 9920 Jefferson Boulevard Culver City, California 90232 / US | [2020/48] | Inventor(s) | 01 /
NIAZI, Kayvan 9920 Jefferson Blvd. Culver City, California 90232 / US | 02 /
TADROS, Wael 9920 Jefferson Blvd. Culver City, California 90232 / US | 03 /
SHIN, Annie 9920 Jefferson Blvd. Culver City, California 90232 / US | [2020/48] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2020/48] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19741284.4 | 15.01.2019 | [2020/48] | WO2019US13633 | Priority number, date | US201862618087P | 17.01.2018 Original published format: US 201862618087 P | [2020/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019143606 | Date: | 25.07.2019 | Language: | EN | [2019/30] | Type: | A1 Application with search report | No.: | EP3740497 | Date: | 25.11.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.07.2019 takes the place of the publication of the European patent application. | [2020/48] | Search report(s) | International search report - published on: | KR | 25.07.2019 | (Supplementary) European search report - dispatched on: | EP | 16.09.2021 | Classification | IPC: | C07K14/47, C12N5/078, C12N15/86, A61K39/00 | [2020/48] | CPC: |
A61K39/001182 (EP,US);
C07K19/00 (US);
A61K39/00 (EP,US);
A61K39/461 (EP,US);
A61K39/4622 (EP,US);
A61K39/464482 (EP,US);
C07K14/575 (US);
C07K14/7051 (US);
C07K14/70539 (EP);
C12N15/102 (US);
C12N15/86 (US);
A61K2039/5256 (EP);
A61K2039/6031 (EP);
C07K2319/03 (EP);
C07K2319/912 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/48] | Title | German: | ERHÖHTE IMMUNOGENITÄT FÜR GPI-VERANKERTE ANTIGENE | [2020/48] | English: | ENHANCED IMMUNOGENICITY FOR GPI-ANCHORED ANTIGENS | [2020/48] | French: | IMMUNOGÉNICITÉ AMÉLIORÉE POUR DES ANTIGÈNES ANCRÉS AU GPI | [2020/48] | Entry into regional phase | 16.07.2020 | National basic fee paid | 16.07.2020 | Search fee paid | 16.07.2020 | Designation fee(s) paid | 16.07.2020 | Examination fee paid | Examination procedure | 16.07.2020 | Examination requested [2020/48] | 07.02.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 25.01.2021 | Renewal fee patent year 03 | 25.01.2022 | Renewal fee patent year 04 | 25.01.2023 | Renewal fee patent year 05 | 25.01.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO03066820 (UNIV CALIFORNIA [US], et al) | International search | [A]WO2005071088 (CERUS CORP [US], et al); | [A]US2005281816 (LAMPING NORBERT [DE], et al); | [A]US2008311137 (LA MONICA NICOLA [IT], et al); | [XY]US2014134201 (TURECI OZLEM [DE], et al); |